Fact CheckerSign in

NCT06528821Active, not recruiting

AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS

Artificial Intelligence-Powered Electrocardiogram Detecting Culprit Vessel Blood Flow Abnormality in Acute Coronary Syndromes

Source: ClinicalTrials.gov · Last updated 20 Mar 2026

Brief summary (registry, in English)

AI ECG TIMI is an investigator-initiated, international, and multicenter registry of acute coronary syndrome patients aimed to identify electrocardiographic findings detected by an AI model predicting coronary blood flow alteration. The aim of the study is to identify electrocardiographic findings detected by an automated artificial intelligence (AI) model that can predict coronary blood flow alteration as assessed by the TIMI grade flow at the very moment of the invasive coronary angiography in patients with acute coronary syndromes.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
800 (estimated)
First submitted
26 Jul 2024
Start date
10 Dec 2024
Primary completion date
16 Mar 2026
Lead sponsor
Powerful Medical
NCT number
NCT06528821

What you commit to

  • Study type: Observational
  • Planned participants: 800
  • From 10 Dec 2024 to the primary completion date, 16 Mar 2026
  • 9 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Individuals presenting for a non-emergent (elective) cardiac catheterization.
  • Individuals presenting with chronic coronary syndrome (CCS) or stable angina symptoms.
  • Individuals without symptoms suspicious for acute coronary syndromes.
  • Individuals with contraindications for cardiac catheterization.

Who the study is looking for

  • Patients with acute coronary syndromes undergoing invasive coronary angiography as clinically indicated.
  • Availability of a standard 12-lead ECG performed at invasive coronary angiogram before percutaneous coronary intervention (maximum within 15 min before vascular access).
  • Age ≥18 years.

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
LKH Hochsteiermark, Standort Bruck
Coordinator of this site? Confirm its status
Bruck an der MurAustriaUnknown status
LKH II Standort West
Coordinator of this site? Confirm its status
GrazAustriaUnknown status
Medical University of Graz
Coordinator of this site? Confirm its status
GrazAustriaUnknown status
OLV Aalst
Coordinator of this site? Confirm its status
AalstBelgiumUnknown status
AZ Sint Jan
Coordinator of this site? Confirm its status
BrugesBelgiumUnknown status
JESSA Ziekenhuis
Coordinator of this site? Confirm its status
HasseltBelgiumUnknown status
University Hospital D'Annunzio Chieti
Coordinator of this site? Confirm its status
ChietiItalyUnknown status
Sant'Andrea Hospital
Coordinator of this site? Confirm its status
RomeItalyUnknown status
San Pietro Hospital
Coordinator of this site? Confirm its status
RomeItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.